News
12-28-2012, 12:20 PM
Breast cancer patients with a certain genetic liver enzyme alteration do not respond well to the hormone therapy tamoxifen as they have difficulty metabolizing the drug, leading to an increased risk of death and recurrence...
More... (http://www.medicalnewstoday.com/articles/254491.php)
More... (http://www.medicalnewstoday.com/articles/254491.php)